Cargando…

Prevalence and predictive modeling of undiagnosed diabetes and impaired fasting glucose in Taiwan: a Taiwan Biobank study

INTRODUCTION: We investigated the prevalence of undiagnosed diabetes and impaired fasting glucose (IFG) in individuals without known diabetes in Taiwan and developed a risk prediction model for identifying undiagnosed diabetes and IFG. RESEARCH DESIGN AND METHODS: Using data from a large population-...

Descripción completa

Detalles Bibliográficos
Autores principales: Chung, Ren-Hua, Chuang, Shao-Yuan, Chen, Ying-Erh, Li, Guo-Hung, Hsieh, Chang-Hsun, Chiou, Hung-Yi, Hsiung, Chao A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277095/
https://www.ncbi.nlm.nih.gov/pubmed/37328274
http://dx.doi.org/10.1136/bmjdrc-2023-003423
_version_ 1785060217305694208
author Chung, Ren-Hua
Chuang, Shao-Yuan
Chen, Ying-Erh
Li, Guo-Hung
Hsieh, Chang-Hsun
Chiou, Hung-Yi
Hsiung, Chao A
author_facet Chung, Ren-Hua
Chuang, Shao-Yuan
Chen, Ying-Erh
Li, Guo-Hung
Hsieh, Chang-Hsun
Chiou, Hung-Yi
Hsiung, Chao A
author_sort Chung, Ren-Hua
collection PubMed
description INTRODUCTION: We investigated the prevalence of undiagnosed diabetes and impaired fasting glucose (IFG) in individuals without known diabetes in Taiwan and developed a risk prediction model for identifying undiagnosed diabetes and IFG. RESEARCH DESIGN AND METHODS: Using data from a large population-based Taiwan Biobank study linked with the National Health Insurance Research Database, we estimated the standardized prevalence of undiagnosed diabetes and IFG between 2012 and 2020. We used the forward continuation ratio model with the Lasso penalty, modeling undiagnosed diabetes, IFG, and healthy reference group (individuals without diabetes or IFG) as three ordinal outcomes, to identify the risk factors and construct the prediction model. Two models were created: Model 1 predicts undiagnosed diabetes, IFG_110 (ie, fasting glucose between 110 mg/dL and 125 mg/dL), and the healthy reference group, while Model 2 predicts undiagnosed diabetes, IFG_100 (ie, fasting glucose between 100 mg/dL and 125 mg/dL), and the healthy reference group. RESULTS: The standardized prevalence of undiagnosed diabetes for 2012–2014, 2015–2016, 2017–2018, and 2019–2020 was 1.11%, 0.99%, 1.16%, and 0.99%, respectively. For these periods, the standardized prevalence of IFG_110 and IFG_100 was 4.49%, 3.73%, 4.30%, and 4.66% and 21.0%, 18.26%, 20.16%, and 21.08%, respectively. Significant risk prediction factors were age, body mass index, waist to hip ratio, education level, personal monthly income, betel nut chewing, self-reported hypertension, and family history of diabetes. The area under the curve (AUC) for predicting undiagnosed diabetes in Models 1 and 2 was 80.39% and 77.87%, respectively. The AUC for predicting undiagnosed diabetes or IFG in Models 1 and 2 was 78.25% and 74.39%, respectively. CONCLUSIONS: Our results showed the changes in the prevalence of undiagnosed diabetes and IFG. The identified risk factors and the prediction models could be helpful in identifying individuals with undiagnosed diabetes or individuals with a high risk of developing diabetes in Taiwan.
format Online
Article
Text
id pubmed-10277095
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-102770952023-06-19 Prevalence and predictive modeling of undiagnosed diabetes and impaired fasting glucose in Taiwan: a Taiwan Biobank study Chung, Ren-Hua Chuang, Shao-Yuan Chen, Ying-Erh Li, Guo-Hung Hsieh, Chang-Hsun Chiou, Hung-Yi Hsiung, Chao A BMJ Open Diabetes Res Care Epidemiology/Health services research INTRODUCTION: We investigated the prevalence of undiagnosed diabetes and impaired fasting glucose (IFG) in individuals without known diabetes in Taiwan and developed a risk prediction model for identifying undiagnosed diabetes and IFG. RESEARCH DESIGN AND METHODS: Using data from a large population-based Taiwan Biobank study linked with the National Health Insurance Research Database, we estimated the standardized prevalence of undiagnosed diabetes and IFG between 2012 and 2020. We used the forward continuation ratio model with the Lasso penalty, modeling undiagnosed diabetes, IFG, and healthy reference group (individuals without diabetes or IFG) as three ordinal outcomes, to identify the risk factors and construct the prediction model. Two models were created: Model 1 predicts undiagnosed diabetes, IFG_110 (ie, fasting glucose between 110 mg/dL and 125 mg/dL), and the healthy reference group, while Model 2 predicts undiagnosed diabetes, IFG_100 (ie, fasting glucose between 100 mg/dL and 125 mg/dL), and the healthy reference group. RESULTS: The standardized prevalence of undiagnosed diabetes for 2012–2014, 2015–2016, 2017–2018, and 2019–2020 was 1.11%, 0.99%, 1.16%, and 0.99%, respectively. For these periods, the standardized prevalence of IFG_110 and IFG_100 was 4.49%, 3.73%, 4.30%, and 4.66% and 21.0%, 18.26%, 20.16%, and 21.08%, respectively. Significant risk prediction factors were age, body mass index, waist to hip ratio, education level, personal monthly income, betel nut chewing, self-reported hypertension, and family history of diabetes. The area under the curve (AUC) for predicting undiagnosed diabetes in Models 1 and 2 was 80.39% and 77.87%, respectively. The AUC for predicting undiagnosed diabetes or IFG in Models 1 and 2 was 78.25% and 74.39%, respectively. CONCLUSIONS: Our results showed the changes in the prevalence of undiagnosed diabetes and IFG. The identified risk factors and the prediction models could be helpful in identifying individuals with undiagnosed diabetes or individuals with a high risk of developing diabetes in Taiwan. BMJ Publishing Group 2023-06-16 /pmc/articles/PMC10277095/ /pubmed/37328274 http://dx.doi.org/10.1136/bmjdrc-2023-003423 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Epidemiology/Health services research
Chung, Ren-Hua
Chuang, Shao-Yuan
Chen, Ying-Erh
Li, Guo-Hung
Hsieh, Chang-Hsun
Chiou, Hung-Yi
Hsiung, Chao A
Prevalence and predictive modeling of undiagnosed diabetes and impaired fasting glucose in Taiwan: a Taiwan Biobank study
title Prevalence and predictive modeling of undiagnosed diabetes and impaired fasting glucose in Taiwan: a Taiwan Biobank study
title_full Prevalence and predictive modeling of undiagnosed diabetes and impaired fasting glucose in Taiwan: a Taiwan Biobank study
title_fullStr Prevalence and predictive modeling of undiagnosed diabetes and impaired fasting glucose in Taiwan: a Taiwan Biobank study
title_full_unstemmed Prevalence and predictive modeling of undiagnosed diabetes and impaired fasting glucose in Taiwan: a Taiwan Biobank study
title_short Prevalence and predictive modeling of undiagnosed diabetes and impaired fasting glucose in Taiwan: a Taiwan Biobank study
title_sort prevalence and predictive modeling of undiagnosed diabetes and impaired fasting glucose in taiwan: a taiwan biobank study
topic Epidemiology/Health services research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277095/
https://www.ncbi.nlm.nih.gov/pubmed/37328274
http://dx.doi.org/10.1136/bmjdrc-2023-003423
work_keys_str_mv AT chungrenhua prevalenceandpredictivemodelingofundiagnoseddiabetesandimpairedfastingglucoseintaiwanataiwanbiobankstudy
AT chuangshaoyuan prevalenceandpredictivemodelingofundiagnoseddiabetesandimpairedfastingglucoseintaiwanataiwanbiobankstudy
AT chenyingerh prevalenceandpredictivemodelingofundiagnoseddiabetesandimpairedfastingglucoseintaiwanataiwanbiobankstudy
AT liguohung prevalenceandpredictivemodelingofundiagnoseddiabetesandimpairedfastingglucoseintaiwanataiwanbiobankstudy
AT hsiehchanghsun prevalenceandpredictivemodelingofundiagnoseddiabetesandimpairedfastingglucoseintaiwanataiwanbiobankstudy
AT chiouhungyi prevalenceandpredictivemodelingofundiagnoseddiabetesandimpairedfastingglucoseintaiwanataiwanbiobankstudy
AT hsiungchaoa prevalenceandpredictivemodelingofundiagnoseddiabetesandimpairedfastingglucoseintaiwanataiwanbiobankstudy